在接受化疗的患者中,SARS-CoV-2的动态进化
Weihua Huang1, Changhong Yin1, Kimberly P Briley1
1Department of Pathology and Laboratory Medicine, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA.
Viruses
|August 26, 2023
概括
在白血病患者中持续的SARS-CoV-2感染揭示了新的尖端蛋白缺失. 这些遗传变化可能会驱动免疫逃生,同时可能降低病毒的传播能力.
科学领域:
- 病毒学 病毒学
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 呈现出显著的基因组进化.
- 持久性病毒感染为研究变体的出现和动态提供了机会.
- 接受化疗的癌症患者可能容易患上长期感染.
研究的目的:
- 在持久性感染中调查SARS-CoV-2的基因组进化.
- 识别新型突变及其对病毒特征的潜在影响.
- 了解免疫功能低下个体的病毒进化轨迹.
主要方法:
- 系列SARS-CoV-2阳性标本的基因组监测.
- 使用序列数据分析病毒尖端蛋白的删除.
- 三维蛋白质结构预测以评估结构影响.
主要成果:
- 在尖端蛋白 N-终端域 (NTD) 中发现了两种前所未有的大型删除 (Δ15-26 和 Δ138-145).
- 在持续感染期间,在这些新变种的产生过程中表现出动态转变.
- 预测蛋白NTD结构的显著变化,可能影响抗原性.
结论:
- 在一个持久性SARS-CoV-2感染的化疗患者中观察到一种新的病毒进化轨迹.
- 在抗原超位点发现的缺失可能有助于免疫逃逸.
- 这些删除可能会降低病毒的传播能力,需要进一步调查.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Viral Mutations
32.4K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.4K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Subviral Agents
41
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
41


